Boletín de AInvest
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Amicus Therapeutics, Inc. (FOLD) shares surged 19.25% in pre-market trading on April 17, 2025, marking a significant rise in investor interest and confidence in the company's prospects.
Amicus Therapeutics has seen notable changes in institutional holdings, with Renaissance Technologies LLC increasing its stake in the company by 174.1% during the fourth quarter. This substantial increase suggests that major investors are bullish on the company's future performance.
Additionally,
has been highlighted as one of the better-ranked stocks in the biotech sector, carrying a strong ranking that indicates positive market sentiment and potential for growth. This recognition further supports the recent surge in the company's stock price.
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Comentarios
Aún no hay comentarios